Yahoo Search Búsqueda en la Web

Resultado de búsqueda

  1. 9 de oct. de 2021 · Based on the best available evidence, we postulate a preferred treatment strategy for Stenotrophomonas maltophilia infection. The best scenario would be to reduce the likelihood of infection entirely through antibiotic stewardship and judicious antibiotic use, particularly of carbapenems, which have been consistently identified in ...

    • PubMed

      Background: In vitro data support the use of combination of...

  2. 13 de oct. de 2022 · Learn about the microbiology, clinical features, and management of S. maltophilia infections, a multidrug-resistant gram-negative bacillus. This article requires subscription to access the full content.

  3. 12 de jun. de 2023 · The first-line treatment is trimethoprim-sulfamethoxazole, which has been the recommended empiric single agent against Stenotrophomonas maltophilia for many years.

  4. 9 de oct. de 2021 · A systematic review of the literature on antimicrobial treatment strategies for Stenotrophomonas maltophilia, an opportunistic and resistant pathogen. The article discusses the current and historical therapies, as well as the novel options such as cefiderocol, avibactam, and aztreonam.

  5. 28 de jul. de 2008 · A systematic review of 49 cases of S. maltophilia infections treated with various antibiotics other than co-trimoxazole. Ciprofloxacin, ceftazidime, ceftriaxone and ticarcillin/clavulanate were found to have high cure or improvement rates.

  6. El objetivo de esta revisión es determinar si el tratamiento con diferentes combinaciones de antibióticos para la Stenotrophomonas maltophilia mejora la función pulmonar o disminuye la frecuencia del ingreso hospitalario en pacientes con fibrosis quística.

  7. 5 de may. de 2022 · Stenotrophomonas maltophilia is a non-fermenting, Gram-negative bacillus that has emerged as an opportunistic nosocomial pathogen. Its intrinsic multidrug resistance makes treating infections caused by S. maltophilia a great clinical challenge.